David Pierce

Board Member

David A. Pierce’s distinguished career at Boston Scientific, spanning 31 years, has been marked by numerous accomplishments and a deep understanding of the MedTech landscape. His expertise in product commercialisation, market access and clinical change management in the Gastrointestinal Endoscopy space positions him as a valuable addition to Mirai Medical’s leadership team.

Meet the Team

We bring together some of the best minds in electroporation and therapeutic development expertise.

DR Declan Soden Founder & CEO of Mirai Medical
Dr. Declan Soden
Founder & Chief Executive Officer
Kieran Moynihan
Chairman
Seán Kinsella
Chief Technical Officer
David Pierce
Board Member
Colin Forde
Chief Operating Officer
Simon Ombler, sales and marketing director at Mirai Medical
Simon Ombler
Sales & Marketing Director
paraic curtis
Paraic Curtis
Board Member
Finn Lyden, baord member of Mirai Medical
Finn Lyden
Board Member
Hilary Devlin
Chief Financial Officer

Recent News

MedTech Innovator Crowns Mirai Medical Among Top Innovators for 2023
Read More
Mirai Medical attends the Australasian Melanoma Conference (AMC) 2023
Read More
Mirai Medical treats the first skin cancer patient in Australia with ePORE® therapy
Read More

Contact Us

By clicking send, you confirm you have read and agreed to Mirai Medical's Privacy Policy.
Twitter Linkedin-in Youtube
ePORE Therapy White Logo
Address:
Mirai Medical
Unit 5, Howley Court
Oranmore
Galway
Ireland
Email:
info@mirai-medical.com
Mirai Medical logo white

© Copyright 2023 MIRAI MEDICAL. All Rights Reserved.

Privacy & Cookies
ePORE® therapy, EndoVE® and CUTIS are approved for commercialisation in the European Union, United Kingdom and Australia. ePORE® therapy, EndoVE® and CUTIS are not cleared by FDA for commercialisation in the USA.

WEEE Ireland Certificate of Registration MIR 100

Website by Proactive Design & Marketing